Some hospitals are pushing low-cost CT scans after a National Cancer Institute study found that CT screening may cut the death rate from lung cancer by 20 percent. Pulmonologist and epidemiologist Peter Bach, MD, was quoted.
A new strategy for genetically bolstering the immune system proved surprisingly powerful against an advanced form of leukemia according to a study published in the New England Journal of Medicine. Medical oncologist Renier Brentjens, MD, PhD, was quoted. Additional interviews with Dr. Brentjens also appeared on ABCNews.com and The Scientist.com.
A study published in the New England Journal of Medicine showed that a new approach to reprogram immune cells to attack cancer is producing encouraging results. Geneticist Michel Sadelain, MD, PhD, was quoted.
The Society of Memorial Sloan-Kettering’s thrift shop kicked off its posh annual fall sale. Executive Director of The Society, Ellen Haddigan, was quoted.
According to a study published in the journal BMC Medicine, herbal medications can cause dangerous side effects when mixed with certain medicines or health conditions. Memorial Sloan-Kettering’s Chief of Integrative Medicine, Barrie Cassileth, PhD, was quoted.
Executive Director of Memorial Sloan-Kettering’s Regional Care Network, Victor Ribaudo, discussed plans to open a regional cancer treatment center in Harrison, NY.
Gynecologic oncologist Douglas Levine discussed how scientists are breaking new ground in their understanding of the genetics — and treatment — of ovarian cancer.
Urologic surgeon Bernard Bochner was interviewed about a published analysis of SEER data that found that nearly all patients with high-grade, primary bladder cancer do not receive guideline-recommended follow-up care.
Breast imaging radiologist Elizabeth Morris discussed a study published in the Journal of the National Cancer Institute that found that women with dense breasts are at a higher risk of breast cancer and are more likely to have aggressive tumors compared to women with less dense breasts.
Breast surgeon Mary Gemignani discussed new breast cancer screening guidelines issued by The American College of Obstetricians and Gynecologists she helped to author.
The Department of Environmental Protection said it suspects that iodine-131, used to treat thyroid cancer, is winding up in Philadelphia’s drinking water intakes from patients excreting excess radioactivity in their urine. Endocrinologist James Fagin and chemist Pat Zanzonico are quoted.
